In vitro Characterization of Peptidomimetic Proteolysis Targeting Chimera (PROTAC) as a Degrader of 3-Chymotrypsin-Like Protease (Mpro/3CLpro) against SARS-CoV-2
Mirko Giuseppe Liturri, Annalisa Bergna, Alessia Lai…·Stefano Rusconi
The paper characterizes FT235, a PROTAC degrader of SARS-CoV-2 3CLpro, showing antiviral activity and reduced cytotoxicity.